ClassID:

92733

C07C233/08 - CPC Classification

Classification description:

Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings

Recent Application in this class:
#1
20240368073
2024-11-07

AMINE-BORANES AS BIFUNCTIONAL REAGENTS FOR DIRECT AMIDATION OF CARBOXYLIC ACIDS

#2
20240174708
2024-05-30

COMPOUNDS FOR TARGETED PROTEIN DEGRADATION

#3
20230257343
2023-08-17

NOVEL AMINO ACID DERIVATIVES

#4
20230102437
2023-03-30

Resin composition and fluidity improvement method

#5
20220242812
2022-08-04

SWELL1-LRRC8 COMPLEX MODULATORS

#6
20220055983
2022-02-24

Amine-boranes as bifunctional reagents for direct amidation of carboxylic acids

#7
20200325098
2020-10-15

Small molecules that specifically inhibit TNF-induced NF-KB inflammation pathway

#8
20200165209
2020-05-28

Method for producing 3-arylpropionamide compound and 3-arylpropionic acid ester compound

#9
20200039922
2020-02-06

HIGH MOBILITY GROUP B1 PROTEIN INHIBITORS

#10
20170210912
2017-07-27

Hydrophilic oil repellent and production method of same, surface coating material, coating film, resin composition, oil-water separation filter material, and porous body

#11
20160137592
2016-05-19

Compounds advantageous in the treatment of central nervous system diseases and disorders

#12
20160090351
2016-03-31

INHIBITORS OF DEUBIQUITINATING PROTEASES

#13
20150111749
2015-04-23

Use of sarmentine and its analogs for controlling plant pests

#14
20140088197
2014-03-27

MIXED CRYSTAL AGOMELATINE (FORM VIII), PREPARATION METHOD AND USE THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

#15
20140045779
2014-02-13

COMPOUNDS CONTAINING AN ALICYCLIE STRUCTURE AND ANTI-TUMOR APPLICATION

#16
20120302541
2012-11-29

4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators

#17
20120165559
2012-06-28

Compounds Having a Physiological Effect

#18
20110021448
2011-01-27

Inhibitors for the soluble epoxide hydrolase

#19
20110021358
2011-01-27

Use of sarmentine and its analogs for controlling plant pests

#20
20100168460
2010-07-01

Process for the preparation of (2R,3S)-3-phenylisoserine methyl ester acetate salt

#21
20100022597
2010-01-28

2-adamantyl-butyramide derivatives as selective 11β-HSD1 inhibitors

#22
20090326266
2009-12-31

PROCESS FOR THE PREPARATION OF GABAPENTIN

#23
20080097122
2008-04-24

Process for the preparation of gabapentin

#24
20070123591
2007-05-31

Gabapentin analogues and process thereof

#25
20070066843
2007-03-22

Process for the preparation of gabapentin

#26
20060270609
2006-11-30

Inhibitors for the soluble epoxide hydrolase

#27
20060025477
2006-02-02

Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases

#28
20050209332
2005-09-22

Gabapentin analogues and process thereof